Metabolic-Fit / 100
Invyncible review
One of the few programs on this list selling both compounded semaglutide/tirzepatide (from $192.50/$210 a month) and the FDA-approved brand pens (Wegovy, Zepbound) itself — plus real transparency about who runs it — but it doesn't publish a state list, so you won't know if it reaches you until you start the intake.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Invyncible at a glance
- Semaglutide
- $192.50/mo
- Tirzepatide
- $210/mo
- Coverage
- Not publicly disclosed; confirmed during intake
- Brand-name
- Yes
How we scored Invyncible
Each factor is scored from Invyncible's real pricing, disclosures and oversight, then combined into the 45/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.invyncible.com/semaglutide-programs
Florida-based; discloses its corporate parent and street address, and displays a LegitScript seal — more transparency than most compounded-only competitors. Every price pair on the programs pages reads as a permanent sale-vs-reference price, not a time-limited promo; we record the lower (sale) figure as the standing price since it's the one shown by default and it's what the checkout flow uses. Unusually, Invyncible sells both compounded programs and the FDA-approved brand drugs (Wegovy, Zepbound) itself rather than routing to a pharmacy partner. No specific state list was found on the public site; 'cancel anytime, no long-term commitment' is stated in its own FAQ. No FDA warning letter found for Invyncible in a dedicated search or in WLR's consolidated enforcement-letter index.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $192.5 | Standard Formula InjectionsListed at $192.50 against a $275.00 reference price. Add-on tiers (Glycine+B12, B12, an oral option) run $149–$262.50/mo; the FDA-approved brand Wegovy is also sold direct on the same site at $1,750/mo (vs. $2,500 list). |
| Compounded tirzepatide | $210 | Standard Formula InjectionsListed at $210.00 against a $300.00 reference price. Add-on tiers (Glycine+B12, B12, B3) run $180–$260/mo; the FDA-approved brand Zepbound is also sold direct at $1,540/mo (vs. $2,200 list). |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Invyncible's public disclosures at last review and change often; confirm the current number on Invyncible's own site.
What we like
- Discloses its corporate parent and a physical address — real accountability, not just a trade name
- LegitScript-verified
- Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on one account
- No long-term commitment; cancel anytime per its own FAQ
The caveats
- No state-availability list published — you find out if it reaches you during intake
- Every price is shown as a permanent 'sale' against a higher reference price, which reads like a discount but never actually changes
- Brand-name Wegovy/Zepbound pricing ($1,540–$1,750/mo) is still well above most insurance-backed options
- Nothing on the site addresses pregnancy, breastfeeding, or postpartum timing specifically
Invyncible for mothers: our verdict
One of the few programs on this list selling both compounded semaglutide/tirzepatide (from $192.50/$210 a month) and the FDA-approved brand pens (Wegovy, Zepbound) itself — plus real transparency about who runs it — but it doesn't publish a state list, so you won't know if it reaches you until you start the intake. It runs about $192.5/month.
We weigh Invyncible the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Invyncible actually costs
- Compounded semaglutide — Standard Formula Injections: $192.5/mo
- Compounded tirzepatide — Standard Formula Injections: $210/mo
That lands within a few dollars of the ~$174/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
The medications Invyncible prescribes
Invyncible prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where Invyncible fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Invyncible is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants the option to start compounded and later move to an FDA-approved brand pen without switching providers, and who values knowing the company's actual name and address.
Alternatives to Invyncible
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Invyncible
Head-to-head & alternatives
Invyncible, answered
- How much does Invyncible cost?
- As last verified, Invyncible's compounded pricing starts around $192.5/month ($192.50/mo semaglutide, $210/mo tirzepatide). Confirm the current, all-in price on Invyncible's own site before you commit.
- Is Invyncible safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use; Invyncible is no exception. Plan any GLP-1 for after weaning, and discuss the timing with your own clinician.
- Does Invyncible offer both semaglutide and tirzepatide?
- Yes — Invyncible offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Invyncible rank for mothers?
- Invyncible scores 45/100 on our Metabolic-Fit Score (rank #80), which weights six factors that matter for mothers. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect Invyncible's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.